- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2009
- Public Summary Document (PSD) November 2009 PBAC Meeting - PDF
Imatinib – November 2009
Imatinib, tablet, 100 mg and 400 mg (as mesylate), Glivec®, November 2009
Last updated
19 March 2010